focus -WSS

focus

author：knowledge 2025-09-07 06:41:21 - browse：39761

The Amgen booth at ESMO in Madrid. Andrew Joseph/STAT

MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug.

The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also published Friday in the New England Journal of Medicine.

“It’s a single arm study, but the results are amazing,” said Silke Gillessen, the scientific chair of ESMO 2023 and an oncologist at the Oncology Institute of Southern Switzerland, noting that advances in small cell lung cancer have been slow to come.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： The problem with charging patients to message their doctors

WSS

Sen. Paul opposes bill to ban Chinese biotechs

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

Novo Nordisk obesity pill bests Wegovy in early trial

The problem with charging patients to message their doctors

Some of the ways extreme heat will change life as we know it

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Wikipedia

focus

hotspot

Cancer drug shortages should be causing more outrage

Air quality improving but still lags in Black, Hispanic communities

BioMarin wins approval for gene therapy to treat hemophilia A

IVF, abortion rights issues kick off Biden’s State of the Union

Hollywood unions extend contract negotiations for actors

An innovative path out of biotech’s “valley of death”

Jerome Adams on the need for new antivirals for Covid

NEJM study link tiny plastics in blood vessels to heart problems

New air purifier tech could be key to improving indoor air quality

In his State of the Union, Biden takes clear aim at 'Big Pharma'

explore

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Sen. Paul opposes bill to ban Chinese biotechs

Precocious puberty in girls comes with mental health risks

Newly revealed memo details efforts to keep Trump in power following election loss

The history of OxyContin, told through Purdue Pharma documents

entertainment

explore

explore

knowledge